Dr Reddy's Shares Slide Over 6¯ter Semaglutide Batch Quality Concern
Dr Reddys Laboratories shares dropped over 4% after a batch of semaglutide was found out of specification due to an active pharmaceutical ingredient issue.
Dr Reddys Laboratories shares dropped over 4% after a batch of semaglutide was found out of specification due to an active pharmaceutical ingredient issue.
